spacer
home > events calendar > more about event
PHARMACEUTICAL INDUSTRY EVENTS CALENDAR

BioTrinity 2019

BIO Trinity 2019

30 April - 1 May 2019
etc.venues 155 Bishopsgate, London EC2M 3YD

BioTrinity 2019 is taking place from the 30thApril – 1st May at etc.venues 155 Bishopsgate in London. Now in its 13th year, BioTrinity remains the leading Life Sciences Biopartnering and Investment conference in Europe, and generates unrivalled opportunities for life science companies, academics, investors, and major pharmaceutical players to come together to do deals and establish collaborations.

BioTrinity 2019 incorporates significant improvements including a move to etc.venues 155 Bishopsgate, a central London location.  This new venue allows us to keep all activity on one floor which will focus the energy and facilitate interaction, thereby maximising visibility for our sponsors, exhibitors, BioLaunchPad® presenters and creating even more opportunities for networking and informal meetings.

The focus of the 2019 conference is to look at 'What’s new' in the industry, and we’ll be providing updates and insight on both technical and financial developments across a wide range of key therapeutics areas – have a look at the Draft Programme.

BioTrinity is developed and organised by OBN, the not-for-profit Membership organisation supporting and bringing together the life sciences industry, their corporate partners and investors.

Social Media:

Twitter - @biotrinity & @OBN_UK

LinkedIn - https://www.linkedin.com/company/1016463/

Website - http://www.biotrinity.com/

Contact:
OBN Events
events@obn.org.uk

phone +44 (0)1235 420870
email events@obn.org.uk
web www.biotrinity.com/
email London
 
Print this page
Send to a friend
   
spacer
Industry Events

FlyPharma Europe

22-23 October 2019, Copenhagen, Denmark

The FlyPharma Conference Europe 2019 is aimed at forward-thinking individuals and businesses that are ready to uncover the potential in their pharma supply chain. The event offers an interactive platform to discuss current and future challenges within pharma and cargo, with topics including market trends, cold chain innovations, latest regulatory demands, security technology, and how to encourage collaboration between supply chain players. There will be plenty of networking opportunities, including a complimentary evening networking event, where delegates can meet and catch up with senior and executive pharma and cargo professionals – gaining strong, new industry contacts and building on existing ones.
More info >>

White Papers

The Promise and Challenge of Adaptive Design in Oncology Trials

Medpace

Clinical oncology trials are more complex and time consuming than those in any other therapeutic area and failure rates are frustratingly high. Given the urgent need for new oncologic therapies, sponsors are eager to find more effective ways to conduct clinical research. Incorporating adaptive design methodologies into clinical trials can reduce costs and enhance efficiency while maintaining trial integrity. They can also reduce the number of patients on placebo and sub-therapeutic doses. In light of this promise, regulatory bodies have created guidelines supportive of adaptive design.
More info >>


News and Press Releases

MedPharm announce expansion of partnership with Palvella Therapeutics in developing a new treatment for the debilitating rare disease, pachyonychia congenita

MedPharm Ltd have announced the expansion of their partnership with Palvella Therapeutics, Inc., a Philadelphia-based biopharmaceutical company focused on developing and commercialising therapies for debilitating, rare genetic diseases. To date, MedPharm has employed its world-renowned specialist formulation expertise to support Palvella’s development of a novel, high-strength rapamycin topical formulation for application to the skin (PTX 022) as a disease-modifying treatment for pachyonychia congenita (PC). Most recently, MedPharm has made arrangements to manufacture the clinical (IMP) batches for use in Palvella’s upcoming Phase 2/3 clinical study.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement